Harrow Health is trading 5% down at $34.70, with no clearly identified company-specific catalyst.
- Extends its decline from $36.58 on September 10, 2026.
- No new company-specific announcement, earnings release, or clearly disclosed catalyst was identified for September 11; latest listed news was September 1.
- The September 9 investor conference had no direct link, while broader markets are sharply higher and do not clearly explain the weakness.